MG
TWST icon

Mather Group’s Twist Bioscience TWST Stock Holding History

Mather Group’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$95 Buy
+2
New +$90 ﹤0.01% 1869
2024
Q3 		– Sell
-38
Closed -$1.3K – 2184
2024
Q2 		$1.3K Buy
+38
New +$1.55K ﹤0.01% 1966

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mather Group's TWST Position: Q1 2026 in Review

Mather Group opened a new position in Twist Bioscience (TWST) in Q1 2026: 2 shares worth $95. The stake represents ﹤0.01% of the portfolio and ranks #1869 among its holdings. This is a return to the name: Mather Group previously reported a position in TWST as recently as Q2 2024.

Mather Group first reported a position in TWST in Q2 2024 and has held it in 2 quarters since. The position peaked at $1.3K in Q2 2024. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Mather Group held 2 shares of Twist Bioscience worth $95 as of Q1 2026.
  • Twist Bioscience was a new Mather Group position in Q1 2026.
  • Twist Bioscience made up ﹤0.01% of Mather Group's portfolio in Q1 2026, its #1869 holding.
  • Mather Group first reported a position in Twist Bioscience in Q2 2024 and has held it in 2 quarters since.
  • Mather Group's Twist Bioscience position peaked at $1.3K in Q2 2024.
  • 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Mather Group's 13F filing for Q1 2026, filed 13 Apr 2026.